# Effects of Microencapsulated Sublingual Glycine (Bidicin) on Cognitive Performance in Healthy Men After an Acute Stressor

> **NCT03353441** · NA · COMPLETED · sponsor: **Daacro** · enrollment: 90 (actual)

## Conditions studied

- Healthy
- Stress, Psychological
- Cognitive Impairment

## Interventions

- **DIETARY_SUPPLEMENT:** Microencapsulated Sublingual Glycine (MSG)
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT03353441
- **Lead sponsor:** Daacro
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-15
- **Primary completion:** 2018-03-15
- **Final completion:** 2018-06-15
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2018-07-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03353441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03353441, "Effects of Microencapsulated Sublingual Glycine (Bidicin) on Cognitive Performance in Healthy Men After an Acute Stressor". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03353441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*